Cas No.: | 331731-18-1 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 98.7% |
SEC-HPLC: | 99.5% |
Isoelectric Point: | Corresponds to reference standard |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | <1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range ofbiological activity is 103% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha. |